On Tuesday, January 3rd, the Food and Drug Administration (FDA) updated labeling for mifepristone (generic for Mifeprex) that would allow pharmacies to dispense the drug.
Unfortunately, both CVS and Walgreens have stated that they will sell the drug in select pharmacies which would place women at greater risk than ever before.